P8‐140: Relationship between response and survival time with immune checkpoint inhibitor combination chemotherapy in advanced non‐small cell lung cancer

doi:10.1111/resp.14150_652

P8‐140: Relationship between response and survival time with immune checkpoint inhibitor combination chemotherapy in advanced non‐small cell lung cancer

Respirology ◽

10.1111/resp.14150_652 ◽

2021 ◽

Vol 26 (S3) ◽

pp. 342-343

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Survival Time ◽

Combination Chemotherapy ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Inhibitor Combination

Download Full-text

P8‐69: Clinical study of chemotherapy with an immune checkpoint inhibitor combination chemotherapy in advanced small cell lung cancer

Respirology ◽

10.1111/resp.14150_581 ◽

2021 ◽

Vol 26 (S3) ◽

pp. 314-315

Keyword(s):

Lung Cancer ◽

Clinical Study ◽

Small Cell Lung Cancer ◽

Combination Chemotherapy ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Inhibitor Combination

Download Full-text

Chemotherapy and immune checkpoint inhibitor combination, a new standard in squamous non-small cell lung cancer?

Translational Lung Cancer Research ◽

10.21037/tlcr.2020.02.08 ◽

2020 ◽

Vol 9 (2) ◽

pp. 401-405

Author(s):

Camille Travert ◽

Pascale Tomasini ◽

Fabrice Barlesi

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Inhibitor Combination

Download Full-text

CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

Case Medical Research ◽

10.31525/ct1-nct04062708 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Stage Iiia

Download Full-text

Safety and Efficacy of Neoadjuvant Immune Checkpoint Inhibitor Therapy in Patients with Resectable Non-small-Cell Lung Cancer: A Systematic Review

Targeted Oncology ◽

10.1007/s11523-021-00818-1 ◽

2021 ◽

Author(s):

Ziran Zhao ◽

Yibo Gao ◽

Qi Xue ◽

Shugeng Gao ◽

Jie He

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Safety And Efficacy ◽

Checkpoint Inhibitor Therapy

Download Full-text

P52.04 Efficacy of Immune Checkpoint Inhibitor Monotherapy for Patients With Massive Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.917 ◽

2021 ◽

Vol 16 (3) ◽

pp. S520-S521

Author(s):

T. Hakozaki ◽

R. Kitadai ◽

S. Kitagawa ◽

Y. Hosomi

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Small Cell ◽

Small Cell Lung

Download Full-text

P09.20 Impact of Antibiotics During Immune Checkpoint Inhibitor (ICI) Therapy for Non-Small Cell Lung Cancer: A Real-World Analysis

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.448 ◽

2021 ◽

Vol 16 (3) ◽

pp. S298

Author(s):

A. Klink ◽

A. Falkenstein ◽

D. Chopra ◽

A. Gajra

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Real World ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Small Cell ◽

Small Cell Lung

Download Full-text

Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-020-04055-7 ◽

2020 ◽

Vol 85 (4) ◽

pp. 761-771 ◽

Cited By ~ 3

Author(s):

Ou Yamaguchi ◽

Hisao Imai ◽

Hiroyuki Minemura ◽

Kensuke Suzuki ◽

Satoshi Wasamoto ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Small Cell ◽

Efficacy And Safety ◽

Small Cell Lung

Download Full-text

Immune checkpoint inhibitor efficacy and safety in elderly non-small cell lung cancer patients

Annals of Oncology ◽

10.1093/annonc/mdy292.095 ◽

2018 ◽

Vol 29 ◽

pp. viii533-viii534

Author(s):

T. Kubo ◽

H. Watanabe ◽

K. Ninomiya ◽

K. Kudo ◽

D. Minami ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Small Cell ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

The efficacy and safety of immune checkpoint inhibitor in patients with relapsed small‐cell lung cancer: A systematic review and meta‐analysis

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13552 ◽

2021 ◽

Author(s):

Yulian Xu ◽

Mingxian Chen ◽

Yanpeng Ding ◽

Feng Guo ◽

Min Chen ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Meta Analysis ◽

Small Cell ◽

Efficacy And Safety ◽

Small Cell Lung

Download Full-text

RE: Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/djab159 ◽

2021 ◽

Cited By ~ 1

Author(s):

Ashley M Hopkins ◽

Ganessan Kichenadasse ◽

Jessica M Logan ◽

Andrew Rowland ◽

Michael J Sorich

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Small Cell ◽

Smoking History ◽

Small Cell Lung ◽

Potential Predictor

Download Full-text